ESC 365 - 3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial

EHRA Premium Access

3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial

Session: Late-Breaking Science: clinical / stroke

Topic: Left Atrial Appendage Closure

Speaker: Doctor R. Galea (Bern, CH)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Roberto Galea

University Hospital, Bern (Switzerland)

1 presentation

1 follower

11 more presentations in this session

Worldwide incidence, management and outcome of systemic embolism following atrial fibrillation ablation: preliminary results from the EMBOL-AF registry.

Speaker: Doctor S. Castrejon Castrejon (Madrid, ES)

Discussant review - EMBOL-AF

Speaker: Professor J. Kalman (Melbourne, AU)

Discussion - EMBOL-AF

Discussant review - SWISS-APERO

Speaker: Professor O. wazni (Cleveland, US)

Discussion - SWISS-APERO

Access the full session

Late-Breaking Science: clinical / stroke

Speakers: Doctor R. Galea, Doctor S. Castrejon Castrejon, Professor J. Kalman, Professor O. wazni

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources